Theoretical advantages of replication-selective, transgene-expressing oncolytic viruses. As several articles in this series show, cytolytic viruses can be engineered that exploit the quirks of cancer cells and spare neighboring tissues. The melding of this technology with gene therapy offers the prospect of safe treatments, enhanced killing of tumor cells, and subtle control over immune responses to tumor cells or viral antigens.